[1]
Z. A. Abdirasulova, B. H. Jabbar, S. H. Ismael, A. M. Hussein, S. Saleh, and N. K. Nazir, “The Usage and Limitations of Gene Therapy Versus Stem Cell Therapy for Myotonic Dystrophy Type 1 (DM1): Special Focus on Immune Response”, Trends Immunother., vol. 10, no. 1, pp. 189–203, Jan. 2026.